Science ❯Biotechnology

Immunotherapy

T Cell Receptor Therapy Vaccine Research Cancer Treatment

BioNTech Settles COVID-19 Vaccine Royalty Disputes for $1.2 Billion

FDA Approves Adaptimmune's Groundbreaking T-Cell Therapy for Rare Cancer